For Irina Barbalova of Euromonitor International, skincare should do well on the market because it is the only segment considered essential, hence the deployment of anti-age products whose growth should reach 5% on average, but also new segments like nutraceuticals, nutricosmetics and beauty supplements. Noninvasive treatments should also continue ...